Abstract
PC-904 was administered to 3 pediatric patients, with serious infections resistant clinically to other antibiotics (2 cases of sepsis and 1 case of pseudormonal pneumonia).
Daily dosage was 100-150 mg/kg and intravenous infusions were carried out in 2 or 3 divided doses.
This drug showed clinically and bacteriologically good response in these patients without any side effect, and was considered to be a useful drug or worthwhile to use in the treatment of the serious infectious diseases such as sepsis or pseudomonal infections.
